PCM
BIOL

Perkins Capital Management’s Biolase, Inc. BIOL Stock Holding History

Perkins Capital Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,572
Closed -$11K – 99
2023
Q2 		$11K Sell
1,572
-25,663
-94% -$430K 0.01% 94
2023
Q1 		$766K Buy
27,235
+26,773
+5,795% +$1.3M 0.72% 46
2022
Q4 		$30K Sell
462
-859
-65% -$124K 0.03% 95
2022
Q3 		$321K Buy
1,321
+138
+12% +$55.2K 0.36% 69
2022
Q2 		$542K Sell
1,183
-43
-4% -$23.6K 0.56% 53
2022
Q1 		$1.08M Buy
1,226
+7
+0.6% +$6.46K 0.89% 44
2021
Q4 		$1.19M Sell
1,219
-35
-3% -$44.1K 0.8% 45
2021
Q3 		$2M Buy
1,254
+5
+0.4% +$8.16K 1.24% 27
2021
Q2 		$2.18M Buy
1,249
+587
+89% +$1.09M 1.24% 30
2021
Q1 		$1.4M Buy
662
+175
+36% +$430K 0.81% 44
2020
Q4 		$507K Buy
487
+43
+10% +$32.8K 0.33% 62
2020
Q3 		$306K Buy
+444
New +$416K 0.28% 71
2020
Q1 		$518K Buy
552
+24
+5% +$37.3K 0.63% 53
2019
Q4 		$729K Buy
+528
New +$812K 0.65% 52
2015
Q1 		– Sell
-26
Closed -$849K – 141
2014
Q4 		$849K Sell
26
-1
-4% -$31.3K 0.73% 54
2014
Q3 		$826K Hold
27
– – 0.7% 56
2014
Q2 		$742K Sell
27
-2
-7% -$51.1K 0.52% 63
2014
Q1 		$860K Buy
29
+14
+93% +$488K 0.6% 59
2013
Q4 		$537K Sell
15
-3
-17% -$71.1K 0.36% 86
2013
Q3 		$434K Buy
+18
New +$580K 0.31% 85

Other funds holding BIOL

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Perkins Capital Management's BIOL Position: Q3 2023 in Review

Perkins Capital Management sold out of Biolase, Inc. (BIOL) in Q3 2023, closing a stake of 1,572 shares — an estimated $11K sold.

Perkins Capital Management first reported a position in BIOL in Q3 2013 and held it in 20 quarters. The position peaked at $2.18M in Q2 2021. 12 funds tracked by Wall St. Rank hold BIOL as of Q3 2023.

  • Perkins Capital Management reported no remaining Biolase, Inc. position as of Q3 2023 after selling out during the quarter.
  • Perkins Capital Management sold 1,572 Biolase, Inc. shares in Q3 2023, an estimated $11K.
  • Perkins Capital Management first reported a position in Biolase, Inc. in Q3 2013 and held it in 20 quarters.
  • Perkins Capital Management's Biolase, Inc. position peaked at $2.18M in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2023.

Based on Perkins Capital Management's 13F filing for Q3 2023, filed 2 Nov 2023.